CTVA
Get informed when a big investor buys or sells
+ FollowJuly 31, 2026 - AI Summary
Undervalued by 903.6% based on the discounted cash flow analysis.
| Market cap | $8.59 Billion |
|---|---|
| Enterprise Value | $11.79 Billion |
| Dividend Yield | $0.72 (4.40%) |
| Earnings per Share | $1.6 |
| Beta | 0.58 |
| Outstanding Shares | 670,400,000 |
| P/E Ratio | 8.53 |
|---|---|
| PEG | -73.26 |
| Price to Sales | 0.48 |
| Price to Book Ratio | 0.34 |
| Enterprise Value to Revenue | 0.66 |
| Enterprise Value to EBIT | 6.44 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.47 |
| Debt to Equity | 0.22 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 67.26% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.95%▼ 88.08% |
|---|---|
| Total Invested | $454.76M▼ 99.10% |
| Investors Holding | 205▼ 1318.00% |
No data
Corteva Agriscience is a publicly traded, global pure-play agriculture company that provides farmers around the world with the most complete portfolio in the industry - including a balanced and diverse mix of seed, crop protection and di...